Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tal Grenader

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Dementia and Geriatric Cognitive Disorders|January 24, 2004
The Fas promoter polymorphism at position -670 is not associated with late-onset sporadic Alzheimer's diseaseHanna Rosenmann, Zeev Meiner, Esther Kahana, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 24, 2004
An association study of a polymorphism in the heparan sulfate proteoglycan gene (perlecan, HSPG2) and Alzheimer's diseaseHanna Rosenmann, Zeev Meiner, Esther Kahana, et al.
Cancer Medicine|July 15, 2015
Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patientsTalia Golan, Tal Grenader, Patricia Ohana, et al.
Anti-Cancer Drugs|June 1, 2017
Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survivalEsther Tahover, Amiel Segal, Rut Isacson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 27, 2016
Immune Monitoring of Patients Treated With a Whole-Cell Melanoma Vaccine Engineered to Express 4-1BBLRoni Engelstein, Sharon Merims, Galit Eisenberg, et al.
Molecular Cancer Therapeutics|August 13, 2011
BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicinTamar Safra, Lucia Borgato, Maria Ornella Nicoletto, et al.
Anti-Cancer Drugs|January 25, 2020
Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumorsTal Grenader, Marianne E Pavel, Philippe B Ruszniewski, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Dementia and Geriatric Cognitive Disorders|January 24, 2004
The Fas promoter polymorphism at position -670 is not associated with late-onset sporadic Alzheimer's diseaseHanna Rosenmann, Zeev Meiner, Esther Kahana, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 24, 2004
An association study of a polymorphism in the heparan sulfate proteoglycan gene (perlecan, HSPG2) and Alzheimer's diseaseHanna Rosenmann, Zeev Meiner, Esther Kahana, et al.
Cancer Medicine|July 15, 2015
Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patientsTalia Golan, Tal Grenader, Patricia Ohana, et al.
Anti-Cancer Drugs|June 1, 2017
Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survivalEsther Tahover, Amiel Segal, Rut Isacson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 27, 2016
Immune Monitoring of Patients Treated With a Whole-Cell Melanoma Vaccine Engineered to Express 4-1BBLRoni Engelstein, Sharon Merims, Galit Eisenberg, et al.
Molecular Cancer Therapeutics|August 13, 2011
BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicinTamar Safra, Lucia Borgato, Maria Ornella Nicoletto, et al.
Anti-Cancer Drugs|January 25, 2020
Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumorsTal Grenader, Marianne E Pavel, Philippe B Ruszniewski, et al.
Pageof 7